Biohaven Ltd. (BHVN) News
Track canonical SquawkNews coverage tagged to BHVN, Biohaven Ltd.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Biohaven Appoints John Yetimoglu To Board
Biohaven appoints new board member
EQUITY | Aug 06, 2026, 11:01 AM UTC
H
BHVN Biohaven to present new clinical data at esmo Congress on bhv-1530, a novel fgfr3-directed Adc with a proprietary topoisomerase I (topo
BHVN Biohaven to present new clinical data at esmo Congress on bhv-1530, a novel fgfr3-directed Adc with a proprietary topoisomerase I (topoix) payload
GEOPOLITICS | Jul 20, 2026, 11:30 AM UTC
H
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Nasdaq Composite falling around 400 points on Friday. Shares of ManpowerGroup Inc (NYSE: MAN ) rose sharply after the company reported upbeat second-quarter results and issued third-quart
EARNINGS | Jul 17, 2026, 02:09 PM UTC
M
Analyst Warns Biohaven's Lead Drug May Struggle To Stand Out
Biohaven Ltd. (NYSE: BHVN ) shares fell Monday after Bank of America Securities (BofA) downgraded the biotechnology company, citing an unfavorable risk-reward profile ahead of a key late-stage epilepsy trial. BofA analys
EQUITY | Jun 29, 2026, 06:04 PM UTC
M
B of A Securities Downgrades Biohaven to Underperform, Lowers Price Target to $11
Bank of America Securities downgrades Biohaven to Underperform.
EQUITY | Jun 29, 2026, 11:44 AM UTC